search
Back to results

High Definition CT Coronary Angiography Accuracy Trial

Primary Purpose

Coronary Artery Disease

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
HD-CTCA with Adaptive statistical iterative reconstruction (ASIR)
Active Comparator: Invasive coronary angiography (ICA)
Sponsored by
University Hospital Plymouth NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring Coronary, Artery, Disease, Diagnostic, Performance, Angiography

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients > 40 years of age.
  • Suspected or known coronary artery disease
  • Admitted for diagnostic ICA

Exclusion Criteria:

  • Consent cannot be obtained
  • Age <40 years
  • New York Heart Association (NYHA) Functional Classification - class III or IV heart failure
  • Emergency imaging required (not enough time to consider the trial)
  • Allergy to iodinated contrast or previous contrast induced nephropathy
  • Intolerance to betablockers
  • Uncontrolled rhythm disturbances (not suitable for CTCA)
  • Serum Creatinine >200 micro mol/L within two weeks prior to procedure or chronic renal failure on dialysis

Sites / Locations

  • Plymouth Hospitals NHS Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Invasive coronary angiography (ICA)

HD-CTCA with ASIR

Arm Description

Routine diagnostic ICA

HD-CTCA with Adaptive statistical iterative reconstruction (ASIR)within 4 weeks of routine diagnostic ICA

Outcomes

Primary Outcome Measures

Diagnostic accuracy of HD-CTCA for the detection of at least moderate stenosis (>50%) as defined on invasive coronary angiography in the high-risk target population.
We designed the New Generation Computed Tomographic Coronary Angiography (NG-CTCA) study to assess the diagnostic accuracy of high-definition CT with iterative reconstruction in an unselected population of patients suitable for CTCA with either a high pre-test probability of, or established coronary artery disease. Our hypothesis is that NGCT has a comparable diagnostic performance to invasive coronary angiography (ICA), using this as the reference standard

Secondary Outcome Measures

The diagnostic accuracy of HD-CTCA for the detection of severe stenosis (70%) as defined by invasive coronary angiography.

Full Information

First Posted
September 3, 2013
Last Updated
September 16, 2013
Sponsor
University Hospital Plymouth NHS Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT01946737
Brief Title
High Definition CT Coronary Angiography Accuracy Trial
Official Title
Diagnostic Performance of 64 Slice High Definition Computed Tomographic Coronary Angiography in Patients With High Risk of Significant Coronary Artery Disease.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2013
Overall Recruitment Status
Completed
Study Start Date
April 2011 (undefined)
Primary Completion Date
August 2012 (Actual)
Study Completion Date
August 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Plymouth NHS Trust

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
CT technology is evolving at a rapid pace, with introduction of multidetector row CT scanners (MDCT) and electrocardiographic (ECG) gating resulting in increasing numbers of heart scans CTCA (CT Coronary Angiography). CTCA provides a noninvasive alternative to conventional invasive coronary angiography (ICA), which is considered the gold standard in the investigation of coronary disease. There has been a gradual increase in the utilization of CTCA for primary assessment of low and intermediate risk patients. However concerns regarding radiation exposure and diagnostic accuracy, especially in the highrisk group, have prevented its widespread dissemination. To achieve best possible temporal resolution (minimize cardiac motion artifacts) and spatial resolution (provide diagnostic accuracy) relatively high radiation exposure is required, as a result of its inverse relationship with image noise and resolution. However radiation (X-ray) is associated with increased risk of cancer in exposed patients and it is therefore essential to continually devise strategies to reduce radiation exposure whilst maintaining image quality. A state-of-art CT scanner (Discovery CT750 HD, General Electric (GE) Healthcare), has been installed at Derriford hospital for further research on CTCA. It uses novel method of scanning, High Definition Computed Tomographic Coronary Angiography(HD-CTCA), analogous to high definition television) and image reconstruction (Adaptive Statistical Iterative Reconstruction ASIR)as opposed to conventional CT scanners using Filtered Back Projection (FBP)reconstruction. HD-CTCA enables acquisition of sharper images and ASIR offsets the resultant increase in radiation exposure. This is likely to result in images of higher diagnostic quality with an equivalent or slightly lower radiation exposure compared to present technology. Although initial results are encouraging, this needs further assessment before being applied to routine clinical practice. To assess this we have designed a study to perform HD-CTCA on 300 consecutive patients undergoing diagnostic ICA at Derriford hospital, directly comparing the accuracy of HD-CTCA to ICA (presently considered the gold standard). Hypotheses: There is no significant difference in the sensitivity and specificity of HD-CTCA for the detection of coronary artery stenosis of 50% or greater compared to conventional ICA.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
Coronary, Artery, Disease, Diagnostic, Performance, Angiography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
302 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Invasive coronary angiography (ICA)
Arm Type
Active Comparator
Arm Description
Routine diagnostic ICA
Arm Title
HD-CTCA with ASIR
Arm Type
Experimental
Arm Description
HD-CTCA with Adaptive statistical iterative reconstruction (ASIR)within 4 weeks of routine diagnostic ICA
Intervention Type
Radiation
Intervention Name(s)
HD-CTCA with Adaptive statistical iterative reconstruction (ASIR)
Intervention Type
Radiation
Intervention Name(s)
Active Comparator: Invasive coronary angiography (ICA)
Primary Outcome Measure Information:
Title
Diagnostic accuracy of HD-CTCA for the detection of at least moderate stenosis (>50%) as defined on invasive coronary angiography in the high-risk target population.
Description
We designed the New Generation Computed Tomographic Coronary Angiography (NG-CTCA) study to assess the diagnostic accuracy of high-definition CT with iterative reconstruction in an unselected population of patients suitable for CTCA with either a high pre-test probability of, or established coronary artery disease. Our hypothesis is that NGCT has a comparable diagnostic performance to invasive coronary angiography (ICA), using this as the reference standard
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
The diagnostic accuracy of HD-CTCA for the detection of severe stenosis (70%) as defined by invasive coronary angiography.
Time Frame
4 weeks
Other Pre-specified Outcome Measures:
Title
The radiation dose delivered by HD-CTCA
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients > 40 years of age. Suspected or known coronary artery disease Admitted for diagnostic ICA Exclusion Criteria: Consent cannot be obtained Age <40 years New York Heart Association (NYHA) Functional Classification - class III or IV heart failure Emergency imaging required (not enough time to consider the trial) Allergy to iodinated contrast or previous contrast induced nephropathy Intolerance to betablockers Uncontrolled rhythm disturbances (not suitable for CTCA) Serum Creatinine >200 micro mol/L within two weeks prior to procedure or chronic renal failure on dialysis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carl Roobottom, BSc, MBChB(hon), MRCP. FRCR
Organizational Affiliation
University Hospital Plymouth NHS Trust
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Srikanth Iyengar, MBBS, MS, FRCS, FRCR
Organizational Affiliation
University Hospital Plymouth NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Plymouth Hospitals NHS Trust
City
Plymouth
State/Province
Devon
ZIP/Postal Code
PL6 8BX
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

High Definition CT Coronary Angiography Accuracy Trial

We'll reach out to this number within 24 hrs